Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Getting Real About Morgellons Disease Gets Harder After Episode of “Criminal Minds"
  • USA - English


News provided by

The Charles E Holman Morgellons Disease Foundation

Oct 27, 2014, 12:45 ET

Share this article

Share toX

Share this article

Share toX

"Cindy's Diary":  A True Morgellons Story
"Cindy's Diary": A True Morgellons Story

Austin, TX. (PRWEB) October 27, 2014 -- The Charles E. Holman Morgellons Disease Foundation (The CEHMDF) received an avalanche of negative feedback concerning the show, "Criminal Minds" that aired Oct 22. A nonprofit organization committed to research, education & awareness and patient support in the battle against Morgellons Disease, the foundation is of the opinion the episode titled, "The Itch," perpetuated many mischaracterizations to Morgellons disease.

“Television shows come and get canceled, but our commitment to saving lives and ending suffering is solid and will stand the test of time,” said Cindy Casey-Holman, R.N.

Post this

"The unrealistic portrayal of suffering people as disturbed, out-of control and criminal is something we take issue with", said Cindy Casey-Holman, RN, Director of the foundation. "In truth, there is no scientific evidence to back up such allegations and we believe it was done simply for dramatic effect," cont'd Casey. However, the foundation expressed concern that this caused unnecessary insult and distress to Morgellons patients’ worldwide. "We have to wonder if it were something more in the public eye such as Ebola or Aids, would the same editorial complacency have been used," commented, Gwen Simmons, RN, CEHMDF Nursing Advisory Board member. The CEHMDF wants to be certain that accurate and current scientific research on the subject of Morgellons is available to avoid confusion and set the record straight.

These facts about Morgellons Disease from the Holman foundation are based in hard science:

1. Morgellons is a physical disease. Morgellons Disease is a multi-system condition characterized by novel skin manifestations and insidious neurological and other systemic symptoms. The distinguishing characteristic of Morgellons Disease (MD) is the presence of microscopic subcutaneous fibers sometimes referred to as filaments within the skin.
Morgellonsdisease.org, (2014). Morgellons Disease Support | The CEHF. [online] Available at: Accessed 25 Oct. 2014.

2. Morgellons disease fibers are composed of keratin and collagen; both proteins made by the body and are not surface debris such as cotton or lint.    Lighted microscopy (60x minimum) enables the visualization of these unusual fibers, often colored red, blue, white or clear, embedded in open skin lesions as well as their presence beneath completely intact skin.
Stricker, R., Middelveen, M., Mayne, P. and Kahn, (2013). Characterization and evolution of dermal filaments from patients with Morgellons disease. Clinical, Cosmetic and Investigational Dermatology, [online] p.1. Available at: Accessed 25 Oct. 2014.

3. Published research substantiates the presence of the pathogenic spirochete (bacteria), Borrelia Burgdorferi, in dermal specimens from Morgellons Disease patients. Multiple peer-reviewed publications, which can be accessed at the foundation’s website and at PubMed.gov, describe these findings including lab analyses in detail.
Middelveen, M., Burugu, D., Poruri, A., Burke, J., Mayne, P., Sapi, E., Kahn, D. and Stricker, R. (2013). Association of spirochetal infection with Morgellons disease. F1000Research. [online] Available at: Accessed 25 Oct. 2014.

In contrast to the fictionalized TV episode, there is a true chronicle of a registered nurse who contracts Morgellons Disease in 2004. Written by her husband as it happened, Cindy's Diary tells the real-life details this woman faced each day while living with this mystery illness. Today, Cindy is the Director of the Charles E. Holman Morgellons Disease Foundation, which was established to research this emerging infectious disease.

The Holman Foundation relies solely on legitimate medical research to gain knowledge and understanding of Morgellons disease. Their ultimate goal is for improved medical management and a cure. “Television shows come and get canceled, but our commitment to saving lives and ending suffering is solid and will stand the test of time,” said Ms. Casey.

     About The Charles E. Holman Morgellons Disease Foundation
The Charles E. Holman Morgellons Disease Foundation, based in Austin, TX, is a 501(c) 3 nonprofit organization committed to advocacy and philanthropy in the battle against Morgellons Disease. The condition affects people of all ages, gender and ethnic groups, worldwide. The foundation was named for Charles E. Holman, a pioneer in the fight against Morgellons Disease, and is led by Director Cindy Casey-Holman, RN. The Holman Foundation will be hosting "The 8th Annual Morgellons Medical Conference" March 28th-29th, 2015 in Austin, TX. Prospective presenters, exhibitors and sponsors for the 2015 Morgellons conference may obtain information at http://www.MorgellonsDisease.org.

Gwen Simmons, RN, The Charles E Holman Morgellons Disease Foundation, http://www.thecehf.org, +1 (901) 252-7494, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.